Joined Today: 0

VION Vion Pharmaceuticals, Stock Message Board

All Messages

VION Message Board Home | Join The VION Group |

#5: Vion Pharmaceuticals Announces Presentation of Data of Cloretazine(R) (VNP40101M) in Elderly Patients with High-Risk Myelodysplastic Syndromes at the EHA Annual Meeting
TheMachine	July 18, 2008 04:43:11 AM
NEW HAVEN, Conn., June 13 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: VION) today announced that data from a previously conducted Phase II... view message ignore post recommend post

#4: Current price of 0.80 today
FastFun	December 11, 2007 07:43:32 AM
I say this little stock grows up very quickly. I think she goes up (maybe sharply) from here. view message ignore post recommend post

#3: Vion Pharmaceuticals Presents Preliminary Data from its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at ASH Annual Meeting
FastFun	December 11, 2007 07:42:24 AM
NEW HAVEN, Conn., Dec. 10 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: VION) today announced that data from its pivotal Phase II trial of its lead anticancer agent... view message ignore post recommend post

#2: Vion Pharmaceuticals To Present Preliminary Data on its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) at the American Society of Hematology Meeting
NewsBot	December 9, 2007 11:04:45 PM
Company to Hold Conference Call on Monday, December 10, 2007 NEW HAVEN, Conn., Dec. 6 /PRNewswire-FirstCall/ -- Vion Pharmaceuticals, Inc. (Nasdaq: VION) today announced that... view message ignore post recommend post

#1: VION, Vion Announces Suspension of Phase III Trial in Relapsed AML
Jason	May 28, 2007 09:32:42 PM
Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly Patients with De Novo Poor-Risk AML Continues to Accrue Patients Company to Hold Conference Call at 10:30 A.M. Eastern Time Today VION... view message ignore post recommend post

Group Home | Login if you want to post a message